Alternatives to Drugtargets

Leveraging the adaptive immune system to diagnose and treat disease.

Caris Life Sciences is a leading innovator in molecular science, offering precision medicine solutions for cancer patients through advanced molecular profiling.

AI-powered platform for personalized cell therapy development and manufacturing.

AI platform for drug discovery and development, optimizing targets, compounds, and combination therapies.

AI-powered platform for antibody discovery and development to create new medicines.

Biotechnology company specializing in antibody discovery and development with integrated 'Idea to IND' solutions.

A global oncology company developing and commercializing innovative cancer treatments.

Clinical-stage genetic medicine company developing AAV-mediated treatments for cardiovascular and Alzheimer's diseases.

Guardant Health is a precision oncology company that develops and commercializes liquid biopsy tests for cancer detection, recurrence monitoring, and treatment selection.

Biopharmaceutical company developing novel therapies for rare and ultra-rare genetic diseases.

Biotechnology company developing gene therapies and regenerative medicine for heart disease.

Biotech company using AI and computational platforms to design novel peptide therapeutics.

Advance every cancer decision.

Clinical-stage biotechnology company developing Antibody Oligonucleotide Conjugates (AOCs) for serious diseases.

A precision biotechnology company developing a blood-based platform for early cancer detection and treatment.

PFx Biotech is developing a novel platform for the discovery and development of protein-based therapeutics.

Gene therapy company developing treatments for rare inherited diseases.

Gene therapy company developing transformative treatments for severe genetic diseases.

Ridge Bio is developing a novel gene therapy platform for treating rare genetic diseases.

Biopharmaceutical company developing antibody-based therapeutics for cancer and autoimmune diseases.